The great strength of the PCWG3 is the recognition that second- , third- , and fourth-line treatments offer new possibilities for extending overall survival.
Rebecca Levine
Advertisement
Articles by Rebecca Levine
Advertisement
Latest Updated Articles
- Oslerian Genomics for Prostate Cancer Oncology
February 15th 2016
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Radiation May Improve Tolerability in Cholangiocarcinoma
2
Distal Extrahepatic Cholangiocarcinoma May Gain From Neoadjuvant Radiation
3
Hydrogel Spacer Receives FDA 510(k) Clearance for Prostate Cancer Radiotherapy
4
Isatuximab-Based Therapy Shows “Impressive” PFS Projections in NDMM
5